>北美自动化细胞培养市场，按产品（消耗品、仪器）、类型（无限细胞系培养、有限细胞系培养）、应用（药物开发、干细胞研究、再生医学、癌症研究、疫苗、其他）、最终用户（生物技术公司、研究组织、学术研究机构、其他）行业趋势和预测到 2029 年。
北美自动化细胞培养市场分析与洞察
自动化细胞培养市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美自动化细胞培养市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2022 年至 2029 年的预测期内，市场将以 9.1% 的复合年增长率增长，预计到 2029 年将达到 77.9702 亿欧元。疫苗生产中对细胞培养技术的需求不断增加，以及 细胞培养技术在各种应用中的广泛接受是推动预测期内市场需求的主要驱动力。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万欧元）、销量（单位）、定价（欧元） |
|
涵盖的领域 |
按产品（消耗品、仪器）、类型（无限细胞系培养、有限细胞系培养）、应用（药物开发、干细胞研究、再生医学、癌症研究、疫苗、其他）、最终用户（生物技术公司、研究组织、学术研究机构、其他）。 |
|
覆盖国家 |
美国、加拿大、墨西哥 |
|
涵盖的市场参与者 |
Lonza、Merck KGaA、Thermo Fisher Scientific Inc.、BD、Eppendorf AG 等 |
北美自动化细胞培养市场定义
自动化细胞培养系统是一种以机械方式执行培养和维持细胞培养物步骤的仪器。自动化细胞培养系统适用于任何从事细胞生物学、细胞信号传导、蛋白质表达或药物发现的实验室，它有助于培养细胞，同时节省人工时间并减少错误。自动化细胞培养系统能够稀释样品、在不断旋转的液体中培养培养物、接种培养物或将培养物放入孔中。3D细胞培养需求的增加、市场参与者之间合作的增加以及外包设施的增加预计将为市场提供丰厚的增长机会。然而，自动化细胞培养系统的高成本以及与自动化细胞培养相关的局限性预计将在预测期内制约市场增长。
北美自动化细胞培养市场动态
本节旨在了解市场驱动因素、机遇、制约因素和挑战。下文将详细讨论所有这些内容：
- 驱动程序
疫苗生产对细胞培养技术的需求不断增加
细胞培养是分子和细胞生物学研究的重要工具。如今，大多数生物技术产品主要依赖于大规模培养细胞系。细胞培养可应用于各种领域，并可作为众多研究工作的模型系统。
政府对细胞研究的资金投入增加，极大地促进了市场的增长。此外，细胞培养技术被广泛用作开发细胞疫苗的当前基于鸡蛋的策略的替代方案。细胞培养在开发具有增加传染病和大流行风险的病毒疫苗方面具有潜在的应用。因此，细胞培养技术被广泛应用于开发美国许可的疫苗，例如针对风疹、天花、水痘、肝炎、轮状病毒和脊髓灰质炎的疫苗。
细胞培养技术系统的技术进步
随着疫苗生产、癌症研究和病毒学等领域对先进细胞培养技术的需求不断增加，自动化细胞培养领域正在取得一定的技术发展。
因此，市场参与者采用细胞培养设备的各种技术发展，以在各个方面促进业务发展并推动市场增长。这一因素可能推动北美自动化细胞培养市场的增长。
- 克制
自动化细胞培养系统成本高
产品成本是市场的主要障碍，因为预计高成本会降低需求。就自动化细胞培养系统而言，价格也很高，低于给定实例将展示产品的价格。
细胞计数器、试剂、缓冲液等仪器和消耗品相关产品的价格很高，这表明自动化细胞培养的成本是预测期内制约北美自动化细胞培养市场的主要因素。
- 机会
新产品发布和技术发展
制药和生物技术驱动的公司正致力于开发和推出新产品和技术，以促进自动化细胞培养的发展，使治疗和诊断方法更加触手可及。这也增加了对 3D 细胞培养的自动化细胞培养市场的需求。新生物反应器、平台和软件的开发促进了自动化细胞培养市场的进步和增长。
新产品和新技术的推出和投入使用为北美自动化细胞培养市场创造了良好的机遇，技术先进的新平台是市场进步的一步。
- 挑战
专业知识的开发和维护
招聘和留住训练有素且合格的员工、员工发展、设备采购的资本预算、运营预算管理、设施基础设施和变革管理都需要适当关注，以促进任何市场的增长和成功。如果不能满足上述任何方面的需求，都可能导致严重的缺陷，如果不加以纠正，可能会损害实验室的信誉，并造成难以在短期内纠正的情况。
测试和维持测试实验室的专业水平是一项艰巨的任务，需要丰富的经验，而这有时是无法获得的，这会阻碍特定公司的发展进程。因此，预计在预测期内，北美自动化细胞培养市场的增长将面临挑战。
最新动态
- 2021 年 8 月，领先的生物加工分析仪器和服务制造商 Advanced Instruments 宣布签署最终协议，收购 Solentim，Solentim 是北美值得信赖的领导者，为细胞系开发 (CLD) 应用中的高价值单细胞克隆的分离和表征提供解决方案。此次收购扩大了两家公司在先进疗法生物工艺工作流程中的地位
- 2021 年 7 月，BD 推出了 bdbiosciences.com，这是一个更新的流式细胞仪数字市场。新网站为流式细胞仪用户及其采购团队提供了增强的在线购买体验
北美自动化细胞培养市场范围
北美自动化细胞培养市场细分为产品、类型、应用和最终用户。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
北美自动化细胞培养市场（按产品划分）
- 耗材
- 仪器
根据产品，北美自动化细胞培养市场细分为耗材和仪器
北美自动化细胞培养市场（按类型）
- 无限细胞系培养
- 有限细胞系培养
根据类型，北美自动化细胞培养市场细分为无限细胞系培养和有限细胞系培养
北美自动化细胞培养市场（按应用划分）
- 药物开发
- 干细胞研究
- 再生医学
- 癌症研究
- 疫苗
- 其他
根据应用，北美自动化细胞培养市场分为药物开发、干细胞研究、再生医学、癌症研究、疫苗和其他。
北美自动化细胞培养市场（按最终用户划分）
- 生物科技公司
- 研究机构
- 学术研究机构
- 其他
根据最终用户，北美自动化细胞培养市场分为生物技术公司、研究组织、学术研究机构和其他。
北美自动化细胞培养市场区域分析/见解
对北美自动化细胞培养市场进行了分析，并按产品、类型、应用和最终用户提供了市场规模信息。
本市场报告涵盖的国家包括美国、加拿大和墨西哥。
2022 年，由于干细胞研究、疫苗生产、再生药物生产和药物发现领域的应用不断增加，北美自动化细胞培养市场预计将实现增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，以及销售渠道的影响。
竞争格局和北美自动化细胞培养市场份额分析
北美自动化细胞培养市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对北美自动化细胞培养市场的关注有关。
北美自动化细胞培养市场的关键市场参与者包括 Lonza、Merck KGaA、Thermo Fisher Scientific Inc.、BD、Eppendorf AG、Advanced Instruments、Benchmark Scientific, Inc.、BioSpherix, Ltd.、Biotron Healthcare、Bulldog Bio、Cell Culture Company, LLC、CellGenix GmbH、ChemoMetec、Corning Incorporated、Cytiva（Danahar Corporation 的子公司）、FUJIFILM Holdings America Corporation、Hemilton Company、Hitachi, Ltd.、Kawasaki Heavy Industries, ltd.、HiMedia Laboratories、NanoEntek America, Inc.、Nexcelom Bioscience LLC.、PromoCell GmbH、RWD Life Science Co., LTD、Sartorius AG、Scientica Instrumentation, Inc.、SHIBUYA CORPORATION、Sphere Fluidics Limited、Tecan Trading AG、Thrive Bioscience, Inc. 等。
研究方法：北美自动化细胞培养市场
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、北美与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORK FOR NORTH AMERICA AUTOMATED CELL CULTURES MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS
6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS
6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS
6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES
6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT
6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS
6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS
6.3.3 INCREASING OUTSOURCING FACILITIES
6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE
6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES
7 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 MEDIA
7.2.1.1 SERUM FREE MEDIA
7.2.1.2 CLASSICAL MEDIA & SALTS
7.2.1.3 STEM CELL CULTURE MEDIA
7.2.1.4 SPECIALTY MEDIA
7.2.2 BUFFERS AND SUPPLEMENTS
7.2.2.1 PLASMA
7.2.2.2 SERA
7.2.2.3 FETAL BOVINE SERA
7.2.2.4 ADULT BOVINE SERA
7.2.2.5 OTHERS ANIMAL SERA
7.2.3 REAGENTS
7.2.3.1 SUPPLEMENTS & GROWTH FACTORS
7.2.3.2 BUFFERS & CHEMICALS
7.2.3.3 CELL DISASSOCIATION REAGENTS
7.2.3.4 BALANCED SALT SOLUTIONS
7.2.3.5 ATTACHMENT & MATRIX FACTORS
7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS
7.2.3.7 CONTAMINATION DETECTION KITS
7.2.3.8 CRYOPROTECTIVE REAGENTS
7.2.3.9 OTHERS CELL CULTURE REAGENTS
7.2.4 ACCESSORIES
7.3 INSTRUMENTS
7.3.1 SUPPORTING EQUIPMENTS
7.3.1.1 CELL COUNTERS
7.3.1.2 IMAGE BASED CELL COUNTERS
7.3.1.3 FLOW CYTOMETERS
7.3.1.4 COULTER COUNTERS
7.3.1.5 CELL EXPANSION
7.3.1.6 LIQUID HANDLERS
7.3.1.7 OTHERS
7.3.2 BIOREACTORS
7.3.2.1 SINGLE USE BIOREACTORS
7.3.2.2 CONVENTIONAL BIOREACTORS
7.3.2.3 OTHERS
7.3.3 STORAGE EQUIPMENTS
7.3.3.1 REFRIGERATORS & FREEZERS
7.3.3.2 CRYOSTORAGE SYSTEMS
7.3.3.3 OTHERS
8 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE
8.1 OVERVIEW
8.2 INFINITE CELL LINE CULTURES
8.3 FINITE CELL LINE CULTURES
9 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DEVELOPMENT
9.3 STEM CELL RESEARCH
9.3.1 EMBRYONIC STEM CELLS
9.3.2 TISSUE-SPECIFIC STEM CELLS
9.3.3 MESENCHYMAL STEM CELLS
9.3.4 INDUCED PLURIPOTENT STEM CELLS
9.4 REGENERATIVE MEDICINE
9.4.1 STEM CELL THERAPY
9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)
9.4.3 TISSUE ENGINEERING
9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS
9.5 CANCER RESEARCH
9.6 VACCINES
9.7 OTHERS
10 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOTECH COMPANIES
10.3 RESEARCH ORGANIZATIONS
10.4 ACADEMIC RESEARCH INSTITUTES
10.5 OTHERS
11 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY REGION
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 COMPANY PROFILE
13.1 LONZA
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.1.6 SWOT ANALYSIS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 RECENT FINANCIALS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 SWOT ANALYSIS
13.3 THERMO FISHER SCIENTIFIC INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 RECENT FINANCIALS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 SWOT ANALYSIS
13.4 BD
13.4.1 COMPANY SNAPSHOT
13.4.2 RECENT FINANCIALS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 SWOT ANALYSIS
13.5 EPPENDORF AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 SWOT ANALYSIS
13.6 ADVANCED INSTRUMENTS
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 BENCHMARK SCIENTIFIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 BIOSPHERIX LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 BIOTRON HEALTHCARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 BULLDOG-BIO, INC.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.11 CELL CULTURE COMPANY, LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
13.12 CELLGENIX GMBH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 CHEMOMETEC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 CORNING INCORPORATED
13.14.1 COMPANY SNAPSHOT
13.14.2 RECENT FINANCIALS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 FUJIFILM HOLDINGS AMERICA CORPORATION
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 HAMILTON COMPANY
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENTS
13.18 HITACHI, LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 KAWASAKI HEAVY INDUSTRIES, LTD.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.2 HIMEDIA LABORATORIES
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
13.22 NEXCELOM BIOSCIENCE LLC.
13.22.1 COMPANY SNAPSHOT
13.22.2 PRODUCT PORTFOLIO
13.22.3 RECENT DEVELOPMENTS
13.23 PROMOCELL GMBH
13.23.1 COMPANY SNAPSHOT
13.23.2 PRODUCT PORTFOLIO
13.23.3 RECENT DEVELOPMENTS
13.24 RWD LIFE SCIENCE CO LTD.
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENTS
13.25 SARTORIUS AG
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT DEVELOPMENTS
13.26 SCIENTICA INSTRUMENTATION, INC.
13.26.1 COMPANY SNAPSHOT
13.26.2 PRODUCT PORTFOLIO
13.26.3 RECENT DEVELOPMENTS
13.27 SHIBUYA CORPORATION
13.27.1 COMPANY SNAPSHOT
13.27.2 RECENT FINANCIALS
13.27.3 PRODUCT PORTFOLIO
13.27.4 RECENT DEVELOPMENTS
13.28 SPHERE FLUIDICS LIMITED
13.28.1 COMPANY SNAPSHOT
13.28.2 PRODUCT PORTFOLIO
13.28.3 RECENT DEVELOPMENTS
13.29 TECAN TRADING AG
13.29.1 COMPANY SNAPSHOT
13.29.2 RECENT FINANCIALS
13.29.3 PRODUCT PORTFOLIO
13.29.4 RECENT DEVELOPMENT
13.3 THRIVE BIOSCIENCE, INC.
13.30.1 COMPANY SNAPSHOT
13.30.2 PRODUCT PORTFOLIO
13.30.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 2 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 3 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 4 NORTH AMERICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 5 NORTH AMERICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 6 NORTH AMERICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)
TABLE 7 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 8 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 9 NORTH AMERICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 10 NORTH AMERICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 11 NORTH AMERICA STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 12 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 13 NORTH AMERICA INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 14 NORTH AMERICA FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 15 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 16 NORTH AMERICA DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 17 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 18 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 19 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 20 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 21 NORTH AMERICA CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 22 NORTH AMERICA VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 23 NORTH AMERICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 24 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 25 NORTH AMERICA BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 26 NORTH AMERICA RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 27 NORTH AMERICA ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 28 NORTH AMERICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 29 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)
TABLE 30 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 31 NORTH AMERICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 32 NORTH AMERICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 33 NORTH AMERICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 34 NORTH AMERICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 35 NORTH AMERICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 36 NORTH AMERICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 37 NORTH AMERICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 38 NORTH AMERICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 39 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 40 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 41 NORTH AMERICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 42 NORTH AMERICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 43 NORTH AMERICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 44 U.S. AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 45 U.S. CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 46 U.S. MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 47 U.S. BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 48 U.S. REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 49 U.S. INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 50 U.S. SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 51 U.S. BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 52 U.S. STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 53 U.S. AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 54 U.S. AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 55 U.S. STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 56 U.S. REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 57 U.S. AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 58 CANADA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 59 CANADA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 60 CANADA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 61 CANADA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 62 CANADA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 63 CANADA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 64 CANADA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 65 CANADA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 66 CANADA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 67 CANADA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 68 CANADA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 69 CANADA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 70 CANADA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 71 CANADA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 72 MEXICO AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 73 MEXICO CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 74 MEXICO MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 75 MEXICO BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 76 MEXICO REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 77 MEXICO INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 78 MEXICO SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 79 MEXICO BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 80 MEXICO STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 81 MEXICO AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 82 MEXICO AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 83 MEXICO STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 84 MEXICO REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 85 MEXICO AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
图片列表
FIGURE 1 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE NORTH AMERICA AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD
FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA AUTOMATED CELL CULTURES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA AUTOMATED CELL CULTURES MARKET
FIGURE 14 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021
FIGURE 15 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)
FIGURE 16 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021
FIGURE 19 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)
FIGURE 20 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021
FIGURE 23 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)
FIGURE 24 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2021
FIGURE 27 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)
FIGURE 28 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)
FIGURE 31 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)
FIGURE 32 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 NORTH AMERICA AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)
FIGURE 35 NORTH AMERICA AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
